期刊文献+

慢性肾病患者行连续性肾脏替代治疗时抗菌药物治疗方案调整的分析与思考 被引量:4

Analysis and reflection on the dose-adjustment of antibiotics for patients with chronic kidney disease in continuous renal replacement therapy
下载PDF
导出
摘要 危重患者行连续性肾脏替代治疗(CRRT)时,受CRRT模式、药物特性及患者病生理状态等因素的影响,抗菌药物的药代动力学和药效动力学参数改变,进而影响抗菌药物给药方案的调整。本文就1例行CRRT治疗的慢性肾病患者应用万古霉素的病例进行分析,探讨CRRT时抗菌药物剂量调整的影响因素。提供个体化给药方案,保证了患者抗感染治疗的安全性和有效性。 When continuous renal replacement therapy(CRRT) is performed in critically ill patients, the pharmacokinetics and pharmacodynamic parameters of antibiotics are affected by some factors, such as CRRT, drug properties and pathophysiological condition of patients, which can in turn affect the administration of antibiotics. This article analyzed the dose adjustment of vancomycin in a patient with chronic renal disease treated with CRRT, and discussed the influencing factors of antibacterial dose adjustment in CRRT. Individualized drug administration can ensure the safety and effectiveness of anti-infective therapy.
作者 白靖 刘江 侯娟 韩雅琦 张坤 陈欣然 胡振杰 BAI Jing;LIU Jiang;HOU Juan;HAN Ya-qi;ZHANG Kun;CHEN Xin-ran;HU Zhen-jie(Department of Pharmacy,the Fourth Hospital ofHebei Medical University,Shijiazhuang 050011,China;Department of ICU,the Fourth Hospital ofHebei Medical University,Shijiazhuang 050011,China)
出处 《天津医药》 CAS 北大核心 2019年第3期281-283,共3页 Tianjin Medical Journal
基金 河北省卫生厅2017年"医学科学研究重点课题计划"(20170768)
关键词 肾病 血液滤过 万古霉素 剂量调整 连续性肾脏替代治疗 nephrosis hemofiltration vancomycin dose adjustment continuous renal replacement therapy
  • 相关文献

参考文献4

二级参考文献34

  • 1Schetz M. Drug dosing in continuous renal replacement therapy: general rules.Curr Opin Crit Care, 2007,13 (6) : 645-651.
  • 2Burgess DS. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Chest, 1999,115 ( 3 Suppl ) : 19s-23 s.
  • 3Moore RD, Lietman PS, Smith CR. Clinical response to aminoglyeoside therapy:importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis, 1987, 155 ( 1 ) : 93-99.
  • 4Ambrose PG, Grasela DM, Grasela TH, et al.Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother,2001,45(10) :2793-2797.
  • 5Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines : a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious DiseasesPharmacists.Clin Infect Dis, 2009,49 ( 3 ) : 325-327.
  • 6Andes D, van Ogtrop ML, Peng J, et al.In Vivo Pharmacodynamics of a New Oxazolidinone ( Linezolid ). Antimicrob Agents Chemother, 2002,46( 11 ) :3484-3489.
  • 7Bugge JF. Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.Acta Anaesthesiol Scand, 2001,45 (8) : 929-934.
  • 8Tian Q, Gomersall CD, Ip M, et al. Adsorption of amikacin, a significant mechanism of elimination by hemofiltration. Antimicrob Agents Chemother,2008,52( 3 ) : 1009-1013.
  • 9Guenter SG, Iven H, Boos C, et al.Pharmacokineties of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofihration in critically ill patients. Pharmacotherapy, 2002,22(2) : 175-183.
  • 10de Pont AC. Extracorporeal treatment of intoxications. Curr Opin Crit Care, 2007,13 (6) : 668-673.

共引文献385

同被引文献38

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部